Aortic aneurysm mechanisms and therapeutic targets
We investigate aortic aneurysm, a highly lethal vascular dilation disease, focusing on how vascular smooth muscle cells, macrophages, perivascular adipose tissue, and genetic variants jointly drive lesion development and rupture risk.
- Identified the smooth muscle TFEB-BCL2 axis as protective in abdominal aortic aneurysm and proposed TFEB activation by cyclodextrin as an intervention strategy.
- Combined GWAS/TWAS with mechanistic studies to reveal the role of TCF7L2 in aortic aneurysm.
- Characterized spatially distinct PVAT remodeling in response to AngII.